These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 37560544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
    Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Palmieri F, Cirillo DM, Ippolito G, Goletti D.
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J, Aksamit TR, Escalante P.
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [Abstract] [Full Text] [Related]

  • 5. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR, Park MS, Cho EH, Jung CW, Kim K, Kim SJ, Oh HY, Huh W, Jang HR, Koh WJ, Park HY, Kim YH, Sinn DH, Choi JO, Joh JW, Kim JM, Kim SJ, Park JB, Kang ES.
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    Kim OH, Jo KW, Park S, Jo YH, Kim MN, Sung H, Shim TS.
    PLoS One; 2020 Nov; 15(6):e0234700. PubMed ID: 32544206
    [Abstract] [Full Text] [Related]

  • 7. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK, Lee HW, Heo EY, Yim JJ, Kim DK.
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [Abstract] [Full Text] [Related]

  • 8. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM.
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [Abstract] [Full Text] [Related]

  • 9. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M, Igari H, Okada N, Suzuki K.
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [Abstract] [Full Text] [Related]

  • 10. QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-tube assays for detecting latent tuberculosis infection in Thai healthcare workers.
    Rudeeaneksin J, Srisungngam S, Klayut W, Bunchoo S, Bhakdeenuan P, Phetsuksiri B.
    Rev Inst Med Trop Sao Paulo; 2023 Jun; 65():e13. PubMed ID: 36753066
    [Abstract] [Full Text] [Related]

  • 11. QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection.
    Kim SH, Jo KW, Shim TS.
    Korean J Intern Med; 2020 Mar; 35(2):383-391. PubMed ID: 31875668
    [Abstract] [Full Text] [Related]

  • 12. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, Ippolito G, Goletti D.
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly.
    Fukushima K, Kubo T, Akagi K, Miyashita R, Kondo A, Ehara N, Takazono T, Sakamoto N, Mukae H.
    J Infect Chemother; 2021 Dec; 27(12):1716-1722. PubMed ID: 34412981
    [Abstract] [Full Text] [Related]

  • 14. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study.
    Xu Y, Yang Q, Zhou J, Zhou F, Hezhang Y, Gao Y, Shao L, Shi J, Ruan Q, Zhang W.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0187021. PubMed ID: 35234509
    [Abstract] [Full Text] [Related]

  • 15. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
    Allen NP, Swarbrick G, Cansler M, Null M, Salim H, Miyamasu M, Howard J, Boyle J, Lewinsohn D, Lewinsohn D.
    Tuberculosis (Edinb); 2018 Dec 27; 113():239-241. PubMed ID: 30514508
    [Abstract] [Full Text] [Related]

  • 16. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S, Pallarès N, Grijota-Camino MD, Sánchez-Montalvá A, Barcia L, Campos-Gutiérrez S, Pomar V, Rabuñal-Rey R, Balcells ME, Gazel D, Montiel N, Vicente D, Goić-Barišić I, Schön T, Paues J, Mareković I, Cacho-Calvo J, Barac A, Goletti D, García-Gasalla M, Barcala JM, Tórtola MT, Anibarro L, Suárez-Toste I, Moga E, Gude-Gonzalez MJ, Naves R, Karslıgil T, Martin-Peñaranda T, Stevanovic G, Trigo M, Rubio V, Karaoğlan İ, Bayram N, Alcaide F, Tebé C, Santin M, ESCMID Study Group for Mycobacterial Infections (ESGMYC) and the Mycobacteria Study Group (GEIM) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
    Microbiol Spectr; 2021 Dec 22; 9(3):e0097221. PubMed ID: 34756079
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.
    Moon HW, Gaur RL, Tien SS, Spangler M, Pai M, Banaei N.
    J Clin Microbiol; 2017 Jun 22; 55(6):1650-1657. PubMed ID: 28298455
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis.
    Pourakbari B, Mamishi S, Benvari S, Mahmoudi S.
    Adv Med Sci; 2019 Sep 22; 64(2):437-443. PubMed ID: 31586819
    [Abstract] [Full Text] [Related]

  • 19. Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting.
    Amofa-Sekyi M, Schaap A, Mureithi L, Kosloff B, Cheeba M, Kangololo B, Vermaak R, Paulsen R, Ruperez M, Floyd S, de Haas P, Fidler S, Hayes R, Ayles H, Shanaube K, TREATS study team.
    PLOS Glob Public Health; 2024 Sep 22; 4(5):e0003182. PubMed ID: 38768253
    [Abstract] [Full Text] [Related]

  • 20. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects.
    Hong JY, Park SY, Kim A, Cho SN, Hur YG.
    J Thorac Dis; 2019 Dec 22; 11(12):5210-5217. PubMed ID: 32030238
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.